• Thurs news: Novartis buys Kate Therapeutics. Trump’s likely FDA pick. Bayer tries for new Nubeqa indications. New CSO for Amgen. Versant developing new type of obesity drug. See more on our front page
Replies
20
Views
10K
Replies
5
Views
247
Replies
593
Views
65K
Replies
12
Views
589
Replies
48
Views
5K
Replies
5
Views
645
Replies
28
Views
4K
Replies
1
Views
193
Replies
35
Views
14K
Replies
6
Views
438
Replies
4
Views
395
  • New replies moderating enabled
Replies
1K
Views
242K